Snapshot
The global Oncology Biosimilars market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Oncology Biosimilars by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
G-CSF
Hematopoietic Agents
Monoclonal Antibodies
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Celltrion Inc.
Pfizer Inc.
Biocon
BIOCAD
Apotex Inc.
Dr. Reddy's
Sandoz International GmbH
Intas Pharmaceuticals Ltd.
STADA Arzneimittel AG
Teva Pharmaceutical Industries Ltd
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Oncology Biosimilars Industry
Figure Oncology Biosimilars Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Oncology Biosimilars
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Oncology Biosimilars
1.2.2 Downstream
Table Application Segment of Oncology Biosimilars
Table Global Oncology Biosimilars Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Oncology Biosimilars Market by Type
3.1 By Type
3.1.1 G-CSF
Table Major Company List of G-CSF
3.1.2 Hematopoietic Agents
Table Major Company List of Hematopoietic Agents
3.1.3 Monoclonal Antibodies
Table Major Company List of Monoclonal Antibodies
3.2 Market Size
Table Global Oncology Biosimilars Market 2016-2020, by Type, in USD Million
Figure Global Oncology Biosimilars Market Growth 2016-2020, by Type, in USD Million
Table Global Oncology Biosimilars Market 2016-2020, by Type, in Volume
Figure Global Oncology Biosimilars Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Oncology Biosimilars Market Forecast 2021-2026, by Type, in USD Million
Table Global Oncology Biosimilars Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Celltrion Inc. (Company Profile, Sales Data etc.)
4.1.1 Celltrion Inc. Profile
Table Celltrion Inc. Overview List
4.1.2 Celltrion Inc. Products & Services
4.1.3 Celltrion Inc. Business Operation Conditions
Table Business Operation of Celltrion Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Pfizer Inc. (Company Profile, Sales Data etc.)
4.2.1 Pfizer Inc. Profile
Table Pfizer Inc. Overview List
4.2.2 Pfizer Inc. Products & Services
4.2.3 Pfizer Inc. Business Operation Conditions
Table Business Operation of Pfizer Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Biocon (Company Profile, Sales Data etc.)
4.3.1 Biocon Profile
Table Biocon Overview List
4.3.2 Biocon Products & Services
4.3.3 Biocon Business Operation Conditions
Table Business Operation of Biocon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 BIOCAD (Company Profile, Sales Data etc.)
4.4.1 BIOCAD Profile
Table BIOCAD Overview List
4.4.2 BIOCAD Products & Services
4.4.3 BIOCAD Business Operation Conditions
Table Business Operation of BIOCAD (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Apotex Inc. (Company Profile, Sales Data etc.)
4.5.1 Apotex Inc. Profile
Table Apotex Inc. Overview List
4.5.2 Apotex Inc. Products & Services
4.5.3 Apotex Inc. Business Operation Conditions
Table Business Operation of Apotex Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Dr. Reddy's (Company Profile, Sales Data etc.)
4.6.1 Dr. Reddy's Profile
Table Dr. Reddy's Overview List
4.6.2 Dr. Reddy's Products & Services
4.6.3 Dr. Reddy's Business Operation Conditions
Table Business Operation of Dr. Reddy's (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Sandoz International GmbH (Company Profile, Sales Data etc.)
4.7.1 Sandoz International GmbH Profile
Table Sandoz International GmbH Overview List
4.7.2 Sandoz International GmbH Products & Services
4.7.3 Sandoz International GmbH Business Operation Conditions
Table Business Operation of Sandoz International GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Intas Pharmaceuticals Ltd. (Company Profile, Sales Data etc.)
4.8.1 Intas Pharmaceuticals Ltd. Profile
Table Intas Pharmaceuticals Ltd. Overview List
4.8.2 Intas Pharmaceuticals Ltd. Products & Services
4.8.3 Intas Pharmaceuticals Ltd. Business Operation Conditions
Table Business Operation of Intas Pharmaceuticals Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 STADA Arzneimittel AG (Company Profile, Sales Data etc.)
4.9.1 STADA Arzneimittel AG Profile
Table STADA Arzneimittel AG Overview List
4.9.2 STADA Arzneimittel AG Products & Services
4.9.3 STADA Arzneimittel AG Business Operation Conditions
Table Business Operation of STADA Arzneimittel AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Teva Pharmaceutical Industries Ltd (Company Profile, Sales Data etc.)
4.10.1 Teva Pharmaceutical Industries Ltd Profile
Table Teva Pharmaceutical Industries Ltd Overview List
4.10.2 Teva Pharmaceutical Industries Ltd Products & Services
4.10.3 Teva Pharmaceutical Industries Ltd Business Operation Conditions
Table Business Operation of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Oncology Biosimilars Sales Revenue 2016-2020, by Company, in USD Million
Table Global Oncology Biosimilars Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Oncology Biosimilars Sales Revenue Share in 2020, by Company, in USD Million
Table Global Oncology Biosimilars Sales Volume 2016-2020, by Company, in Volume
Table Global Oncology Biosimilars Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Oncology Biosimilars Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Oncology Biosimilars Market Concentration, in 2020
Figure Europe Oncology Biosimilars Market Market Concentration, in 2020
Figure Asia-Pacific Oncology Biosimilars MMarket Concentration, in 2020
Figure South America Oncology Biosimilars Market Concentration, in 2020
Figure Middle East & Africa Oncology Biosimilars Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Retail Pharmacies
Figure Oncology Biosimilars Demand in Retail Pharmacies, 2016-2020, in USD Million
Figure Oncology Biosimilars Demand in Retail Pharmacies, 2016-2020, in Volume
6.1.2 Demand in Hospital Pharmacies
Figure Oncology Biosimilars Demand in Hospital Pharmacies, 2016-2020, in USD Million
Figure Oncology Biosimilars Demand in Hospital Pharmacies, 2016-2020, in Volume
6.1.3 Demand in Online Pharmacies
Figure Oncology Biosimilars Demand in Online Pharmacies, 2016-2020, in USD Million
Figure Oncology Biosimilars Demand in Online Pharmacies, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Oncology Biosimilars Demand Forecast 2021-2026, by Application, in USD Million
Figure Oncology Biosimilars Market Growth 2021-2026, by Application, in USD Million
Figure Oncology Biosimilars Market Share in 2026, by Application, in USD Million
Table Oncology Biosimilars Demand Forecast 2021-2026, by Application, in Volume
Table Oncology Biosimilars Market Growth 2021-2026, by Application, in Volume
Table Oncology Biosimilars Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Oncology Biosimilars Production 2016-2020, by Region, in USD Million
Table Oncology Biosimilars Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Oncology Biosimilars Market 2016-2020, by Region, in USD Million
Table Global Oncology Biosimilars Market Share 2016-2020, by Region, in USD Million
Table Global Oncology Biosimilars Market 2016-2020, by Region, in Volume
Table Global Oncology Biosimilars Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Oncology Biosimilars Market Size and Growth 2016-2020, in USD Million
Figure North America Oncology Biosimilars Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Oncology Biosimilars Market Size 2016-2020, by Country, in USD Million
Table North America Oncology Biosimilars Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Oncology Biosimilars Market Size and Growth 2016-2020, in USD Million
Figure Europe Oncology Biosimilars Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Oncology Biosimilars Market Size 2016-2020, by Country, in USD Million
Table Europe Oncology Biosimilars Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Oncology Biosimilars Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Oncology Biosimilars Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Oncology Biosimilars Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Oncology Biosimilars Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Oncology Biosimilars Market Size and Growth 2016-2020, in USD Million
Figure South America Oncology Biosimilars Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Oncology Biosimilars Market Size 2016-2020, by Country, in USD Million
Table South America Oncology Biosimilars Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Oncology Biosimilars Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Oncology Biosimilars Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Oncology Biosimilars Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Oncology Biosimilars Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Oncology Biosimilars Market Forecast 2021-2026, by Region, in USD Million
Table Oncology Biosimilars Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion